Digital download
Access the files immediately after checkout.
Procter & Gamble Boston Consulting Group Matrix
Included with this resource
Word + Excel files
Edit, adapt and present the analysis in familiar formats.
Four portfolio quadrants
Map Stars, Cash Cows, Question Marks and Dogs.
Resource allocation
Compare where to invest, maintain or rationalize.
Growth and share view
Turn portfolio position into clear priorities.
Actionable Strategy Starts Here
Procter & Gamble’s BCG Matrix snapshot shows clear market leaders and aging categories—some brands are Stars driving growth, others are Cash Cows funding innovation, and a few face tough choices. Want the full picture with quadrant-by-quadrant placements, data-backed recommendations, and tactical next steps? Purchase the complete BCG Matrix to get a detailed Word report plus a high-level Excel summary you can present and act on immediately. Skip the guesswork—get clarity and a ready-to-use strategy now.
Stars
Tide & Ariel premium formats (Pods/liquids)
Tide and Ariel lead P&G's fabric care with commanding shares—Tide alone holds about 40% of the US laundry market—while premium Pods and liquid formats are still expanding globally. Heavy ad spend and aggressive shelf placement keep velocity high, translating premiumization into faster turnover. Continued investment is warranted to defend leadership as categories premiumize; if growth moderates, this engine will convert into a high-margin cash generator.
Oral-B power brushing & connected devices
Premium oral care is growing rapidly, with the electric toothbrush segment forecasted to expand at roughly 7% CAGR through 2030, and Oral-B iO positioned at the premium top of P&G’s portfolio. Hardware sales plus recurring brush head refills create an annuity model, but broader adoption still requires sustained marketing spend and stronger dental channel push. App tie-ins and data capture deepen the competitive moat, enabling recurring revenue and lifetime value uplift—win share now, bank cash later.
Downy/Lenor scent-boosters
Downy/Lenor in-wash scent-boosters sit in a high-growth BCG question-mark turning star role as in-wash beads expand rapidly in emerging markets; P&G leads the category within its Fabric & Home Care business (reported roughly $13.7B net sales in FY2024). High growth requires heavy reinvestment—sampling, end-cap displays and influencer campaigns—to defend slotting and convert trial into routine. Keep the gas on to make scent-beads the default format.
Febreze air care
Febreze air care
Febreze remains a Star in P&G’s BCG matrix as post‑pandemic air‑care penetration and usage occasions expanded; the global air‑care market reached about $11B in 2024 and continues mid‑single‑digit CAGR. Febreze owns strong mindshare but must refresh formats and fragrances and lean on heavy promo calendars and retailer partnerships to sustain growth or cede share.- Position: Star
- 2024 market: ~$11B
- Drivers: new formats, fragrances, promo calendars
- Risk: loss of momentum to nimble challengers
SK-II (select Asian markets)
SK-II in select Asian markets sits as P&G’s prestige lead, benefiting from the ultra-premium beauty segment that remained positive through 2024; P&G reported ~3% organic sales growth in fiscal 2024, underpinning momentum in prestige lines.
High average selling prices amplify marketing and service intensity; consistent storytelling across China and SEA travel retail is required to sustain premium equity, which compounds over time.
- Position: prestige leader in select Asian markets
- Market context: ultra-premium beauty positive in 2024
- Financial signal: P&G ~3% organic sales growth FY2024
- Priority: consistent storytelling, high-touch service, protect equity
Laundry leader ~40%; air-care market $11B
Tide/Ariel are Stars—Tide ~40% US laundry share and P&G Fabric & Home Care ~$13.7B FY2024—premium Pods drive volume and margin. Oral‑B iO targets ~7% electric toothbrush CAGR to 2030; hardware+refills form an annuity but need sustained marketing. Febreze is a Star in a ~$11B 2024 air‑care market; refresh formats and promos to sustain growth.
| Brand | Position | 2024 metric | Priority |
|---|---|---|---|
| Tide/Ariel | Star | ~40% US share; Fabric & Home Care $13.7B | Defend premium, invest in shelf & ads |
| Oral‑B iO | Star | ~7% CAGR to 2030 | Drive adoption, subscription refills |
| Febreze | Star | Air‑care ~$11B (2024) | Refresh formats, heavy promos |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix review of P&G products, identifying Stars, Cash Cows, Question Marks and Dogs with strategic recommendations.
Customizable Excel Spreadsheet
One-page Procter & Gamble BCG Matrix resolving portfolio blind spots for faster strategy decisions
Cash Cows
Pampers core diapers
Pampers core diapers occupy a mature developed-market category where Pampers holds roughly 35% share and generated about $7.8 billion in sales for P&G in 2024; scale drives gross margins, so modest supply‑chain improvements (1% cost reduction) flow almost directly to operating cash. Marketing remains efficient—prioritize defend-over-spend to protect share. Milk steady cash to fund newer growth bets.
Gillette blades & razors
Gillette blades and razors remain a classic cash cow for Procter & Gamble: slower category growth but clear pricing power, with Grooming net sales around $7 billion in FY2024 supporting high margins. Strong brand loyalty and refill economics deliver steady free cash flow, funding operations and dividends. Capital allocation favors periodic innovation bursts (new blade systems, subscription pushes) rather than continuous heavy investment.
Tide & Ariel core powders/liquids (mainline)
Tide and Ariel mainline powders/liquids are classic cash cows: mass detergent is stable and P&G effectively owns the aisle with top market positions, and Fabric & Home Care drove roughly $27 billion in sales in fiscal 2024. Manufacturing scale and enduring brand equity support above-average gross margins, while promotions are surgical rather than constant to protect pricing. Strong cash flow from these brands underwrites R&D and channel investment, funding innovation and retailer partnerships.
Always & Tampax
Always and Tampax function as P&G cash cows in a steady feminine-care category with sticky brand loyalty. P&G maintains high share through disciplined promotions and a steady innovation cadence; P&G reported fiscal 2024 net sales of $84.3 billion. Infrastructure efficiencies and SKU optimization are squeezing incremental margin, making these brands a dependable funder of growth.
- High share
- Sticky loyalty
- Disciplined promo + innovation
- Margin tailwinds
- Funds growth from P&G $84.3B FY2024 sales
Crest toothpaste (mass)
Toothpaste category growth was modest in 2024 (≈2%), and Crest retained roughly a 25% share of US toothpaste sales, holding its lane within Procter & Gamble’s portfolio. The brand throws off steady cash from scale and daily recurring use, enabling predictable margins and free cash flow. Priority: keep trade spend efficient and defend core SKUs to preserve this bankable cash cow.
- 2024 category growth ≈2%
- Crest ≈25% US market share (2024)
- High recurring purchase frequency = predictable cash
- Focus: efficient trade spend, defend core SKUs
Household giants: diapers, grooming, fabric care, oral care generate steady FCF
P&G cash cows (2024): Pampers ~35% share, $7.8B; Gillette Grooming ~$7B; Tide/Ariel central to Fabric & Home Care ~$27B; Crest ~25% US share—scale, pricing power and disciplined promo generate steady FCF to fund growth bets.
| Brand | 2024 metric |
|---|---|
| Pampers | 35% share, $7.8B |
| Gillette | Grooming ~$7B |
| Tide/Ariel | Fabric & Home Care $27B |
| Crest | ~25% US share |
What You See Is What You Get
Procter & Gamble BCG Matrix
The file you're previewing is the exact BCG Matrix you'll receive after purchase—no watermarks, no demo pages, just the finished, fully formatted report. It's built for clarity and quick decisions, so you can drop it into presentations or strategy sessions without fiddling. Once bought, the same document is sent straight to your inbox and is immediately editable and printable. Crafted with market-backed insight, it’s ready to use by your team or clients.
Dogs
Luvs (value diapers, US)
Luvs, P&G's value diaper brand, sits in a low-growth US diaper segment where private-label penetration has steadily increased, compressing price margins and forcing heavy promotion.
Market share for Luvs remains limited and promo-dependent; after retailer discounts and trade spend, cash returns are thin versus premium Pampers.
Given constrained category growth and margin pressure, heavy turnarounds are hard to justify — maintain the franchise or prune underperforming SKUs.
Safeguard bar soap (select markets)
Safeguard bar soap sits in a mature, low-growth bar-soap category with intense price competition that limits margin expansion; P&G reported fiscal 2024 net sales of about $82.1 billion, underscoring scale but not growth for commodity bars.
Limited product differentiation has stalled share gains in select markets, while cash is tied up in shelf space and frequent small promotions that compress ROI.
Where Safeguard underperforms versus regional competitors, the brand is a clear Dog in the BCG matrix and merits tight-focus investment or strategic exit to redeploy capital.
Herbal Essences (legacy lines)
Herbal Essences legacy lines face SKU crowding and low velocity across many variants, with churn rates in mature hair-care shelves limiting shelf share despite pockets of growth in clean-beauty and salon-inspired segments. Revitalization costs—marketing, reformulation and trade spend—often exceed incremental returns, prompting P&G to rationalize SKUs to free space for faster horses. Global hair-care market was about US$101 billion in 2024, highlighting the need to prioritize higher-velocity SKUs.
Braun low-end grooming appliances
Braun low-end grooming appliances sit as Dogs in P&G’s BCG matrix: low growth, limited market share, and margin pressure from aggressive online value competitors; Braun has been part of Procter & Gamble since 2005. Inventory risk ties up cash as promotional pricing compresses margins, so broad push and heavy investment are not justified.
- Trim assortment to SKUs that turn
- Prioritize cash-positive items
- Exit loss-making low-end slots
- Redirect spend to higher-growth segments
Minor home-care tail brands (regional)
Minor home-care tail brands within P&G are small, region-bound labels that tie up working capital without scale, typically representing under 2% of total net sales in 2024 and delivering single-digit CAGR; low growth, low market share and limited strategic value mean these SKUs rarely clear corporate hurdle rates (often below an 8% ROI threshold) and erode margin and inventory turns.
- Under 2% of 2024 net sales
- Single-digit CAGR, low share
- ROI typically <8%
- Recommend divest or sunset to simplify shelf
Cut low-return SKUs, halt loss-making low-end lines, reinvest in premium growth
Luvs, Safeguard, low-end Braun and minor home-care SKUs are Dogs: low growth, thin share, heavy promo pressure and constrained returns. P&G fiscal 2024 net sales ~US$82.1B; minor tails <2% of sales and often ROI <8%. Prune SKUs, stop loss-making low-end lines, redeploy spend to Pampers, premium hair-care and higher-velocity segments.
| Brand | 2024 est. sales | Market pos | Action |
|---|---|---|---|
| Luvs | Low (single-digit % of diaper) | Low share | Prune/maintain core |
| Safeguard | Commodity | Declining | Exit where weak |
| Braun (low-end) | Minor | Low | Exit/divest |
Question Marks
Zevo insect control
Zevo sits in a fast-growing, seasonal insect-control niche with strong consumer curiosity but low overall penetration; pilot retail and DTC velocity rose roughly 300% in 2024 in test markets, showing scalable demand. Marketing and education remain heavy lifts given low category familiarity and seasonality. If retail repeat and DTC compounding continue, Zevo can scale into category leadership, so it is worth a strategic push while the category is shaping.
Microban 24 disinfectants
Microban 24 sits as a Question Mark in P&G’s BCG matrix: the disinfectant category cooled post‑pandemic, with U.S. household disinfectant sales down roughly 35% from 2020 peaks to 2024 (NielsenIQ), yet elevated hygiene habits persist. Brand awareness for Microban 24 is decent but market share remains small versus incumbents, requiring tight positioning and superior retail execution to gain distribution. P&G should double down selectively in high‑growth channels or pivot the SKU/messaging to adjacent uses to improve ROI.
GilletteLabs premium devices
High-ticket razors with tech flair (GilletteLabs Heated Razor launched at $199.99) are expanding from a small base. Trial is the hurdle; refill cartridges (around $4.99 each) unlock the recurring-revenue model and higher lifetime value. Smart campaigns and premium placements could tip adoption; if uptake stalls, P&G should refocus investment on core Gillette blades and disposables.
Oral-B subscription/refill ecosystems
Oral-B subscription/refill sits as a Question Mark in P&G’s BCG matrix: the repeat purchase model aligns with ADA guidance to replace brush heads every three months, but consumer habit remains retail-first. UX, competitive pricing, and retail/channel partnerships will determine scale; reducing churn and increasing basket size would shift it toward Star, otherwise keep it niche and lean.
Sustainable formats (EC30/low-waste pilots)
Question Marks: sustainable formats (EC30/low-waste pilots) attract high consumer interest but slow behavior change; 2024 pilots show strong engagement among eco-minded shoppers while remaining niche, and P&G maintains its 2030 goal of 100 percent recyclable or reusable packaging. Success requires education, trial programs and price alignment; invest where trial-to-repeat is rising, cut where adoption stalls.
- High interest, low mass adoption
- Early pilots: niche urban/eco segments
- Needs education, sampling, price work
- Invest where acceptance grows; divest where static
Back repeat pilots (+300%); cut cooling lines (-35%)
Question Marks (Zevo, Microban 24, GilletteLabs, Oral‑B refill, sustainable formats) show strong early traction but low share: Zevo pilot velocity +300% in 2024; U.S. disinfectant sales down ~35% from 2020–2024 (NielsenIQ); GilletteLabs launch price $199.99, refills ~$4.99; P&G 2030 recyclable goal. Invest where repeat rises, divest where adoption stalls.
| Brand | 2024 signal | Key metric |
|---|---|---|
| Zevo | pilot growth | +300% velocity |
| Microban 24 | category cooling | -35% sales vs 2020 |
| GilletteLabs | premium trials | $199.99 launch; $4.99 refill |
| Oral‑B refill | subscription potential | ADA 3‑mo replace |
| Sustainable | niche pilots | 2030 100% recyclable goal |